Which target blood pressure is optimal for renoprotection?
Marcin Adamczak,
Jerzy Chudek
and
Andrzej Wi
cek*
Correspondence *Department of Nephrology, Endocrinology and Metabolic Diseases, Medical University of Silesia, Francuska 20/24 Street, 40-027 Katowice, Poland
Email awiecek@spskm.katowice.pl
Elevated blood pressure is a strong and independent risk factor for the development of end-stage renal disease. Various investigators have examined whether all renal diseases are similarly sensitive to high blood pressure and whether they benefit similarly from antihypertensive therapy. Reviewing data from different renal disease populations, authors from the Medical University of Silesia provide their recommendations on the optimal blood pressure goals for slowing progression of renal insufficiency.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
